Larry Norton, MD
Larry Norton, MD, is deputy physician in chief for breast cancer programs at Memorial Sloan-Kettering Cancer Center in New York and medical director of MSKCC’s breast and imaging center. He is a professor of medicine at the Weill Medical College of Cornell University in Ithaca, N.Y. He has dedicated his life to the eradication of cancer through medical care, laboratory and clinical research, advocacy and government.
Dr. Norton is the principal investigator of an NCI program project grant in models of human breast cancer. He is the founding incumbent of the Norna S. Sarofim Chair of Clinical Oncology at MSKCC and a founder of the Breast Cancer Research Foundation, where he serves as scientific director. Dr. Norton has served in various roles for a variety of foundations and organizations, including the American Society of Clinical Oncology, National Cancer Advisory Board, National Cancer Institute, National Institutes of Health, Institute of Medicine of the National Academy of Sciences and the breast committee of the Cancer and Leukemia Group B. He is an editorial board member and reviewer for numerous medical journals, and he is also an author to more than 350 articles and many book chapters. Dr. Norton has served as a visiting professor at institutions throughout the U.S., Canada, South America, Europe and Asia. Dr. Norton’s research focuses on developing approaches to diagnosing, preventing and treating cancer, particularly the application of mathematical methods to optimizing dose and schedule. He has been involved in the development of several effective agents, including paclitaxel (Taxol) and trastuzumab (Herceptin). He co-invented the Norton-Simon Model of cancer growth, which has broadly influenced cancer therapy, and the self-seeding concept of cancer metastasis and growth.
For his work, Dr. Norton has received many honors and recognitions from institutions such as the M.D. Anderson Cancer Center, the Society for MSKCC, Susan G. Komen for the Cure and The Breast Cancer Research Foundation. He received ASCO’s highest honor, the David A. Karnofsky Award, and was a McGuire Lecturer at the San Antonio Breast Cancer Symposium.